ASBMB Annual Meeting

Gingras studies proteomics’ implications for research

She will present her work at the ASBMB 2020 annual meeting Molecular & Cellular Proteomics session
Adriana Bankston
March 06, 2020

When Anne-Claude Gingras was working on her Ph.D. in Nahum Sonenberg’s lab at McGill University, she focused on the regulation of the protein synthesis machinery by phosphorylation. Her thesis described the role of the mechanistic target of rapamycin complex in phosphorylating a translational inhibitor.

The ASBMB annual meeting at EB has been canceled. This decision comes as COVID-19 spreads, institutions restrict travel and jurisdictions declare states of emergency. Read the letter sent to attendees.
Gingras-Anne-Claude-300x300.jpg
Anne-Claude Gingras

Curious about the unexplored protein phosphatase components of phosphoregulation, Gingras realized that then-emerging proteomics technologies would be key to solving this puzzle. She moved to Seattle to study mass spectrometry with Ruedi Aebersold, and there she improved methods for protein–protein interaction detection. She started her own research group in late 2005.

Gingras now runs a signal transduction, systems biology and proteomics lab at the Lunenfeld–Tanenbaum Research Institute in Toronto. Her team works to improve experimental and computational approaches for interaction proteomics. Misregulation of protein phosphorylation is implicated in numerous diseases, including cancer and diabetes, so she applies these techniques to identify and understand new components of signaling pathways related to these pathologies. More recently, she began systematically applying the proximity-dependent biotinylation approach BioID to study the composition and organization of membraneless organelles and, ultimately, of human cells.

Her group’s success in defining new biological complexes and pathways implicated in disease heavily relies on the contributions of talented students, fellows and research assistants with diverse expertise in biochemistry, cell biology, mass spectrometry and bioinformatics, as well as a large network of key scientific collaborators.

Her Ph.D. and postdoc advisors shaped not only her scientific directions but also how she interacts with other scientists, Gingras said. She is committed to sharing data, methods, reagents and protocols and to helping other scientists realize their objectives. Her motto, she said, is “Science works much faster when you help one another.”

Tools for studying proteomics changes in organelles

To determine where proteins are in a cell, Anne-Claude Gingras’ group uses mass spectrometry as a high-resolution discovery-based microscope. They employ a technique known as BioID that reports on the proximity of a protein to another used as bait.

Her student Christopher Go created 200 stable cell lines that each express one organelle marker as a probe and performed proximity-dependent biotinylation to identify the composition of each organelle. Research associate James Knight then developed computational tools to analyze and visualize the data. This project revealed new addresses for many unexplored proteins and showed proteins that are at contact interfaces between organelles. The resulting paper has been published as a preprint in bioRxiv.

Using this work as a reference map, others in the Gingras lab are creating sensors to report on proteomic changes in an organelle after perturbations such as drug treatment, various growth conditions and genetic modulation with CRISPR. In profiling the surface of the lysosome, postdoctoral fellow Geoffrey Hesketh found a new pathway that activates the mechanistic target of rapamycin complex by extracellular protein through the process of macropinocytosis. This work has implications for disease in which macropinocytosis is activated, such as Ras-dependent cancers.

Adriana Bankston

Adriana Bankston is principal legislative analyst at the University of California Office of Federal Governmental Relations, chief outreach officer of the Journal of Science Policy and Governance, and a member of the Future of Research board of directors. This post represents the writer's personal views and not the views of their employer, University of California.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Herbert Tabor 1918 – 2020
Retrospective

Herbert Tabor 1918 – 2020

September 24, 2020

F. Peter Guengerich remembers the contributions of the longtime editor of the Journal of Biological Chemistry who died in August.

ASBMB welcomes new members
Member News

ASBMB welcomes new members

September 21, 2020

The American Society for Biochemistry and Molecular biology welcomed more than 60 new members in April.

It all comes down to where we place our bets
Interview

It all comes down to where we place our bets

September 18, 2020

Mark Harpel works in a research unit at GlaxoSmithKline that helps choose the most promising targets for new drug development.

Understanding the impact of Type 1 diabetes susceptibility genes
Research Spotlight

Understanding the impact of Type 1 diabetes susceptibility genes

September 17, 2020

Starting in eighth grade, a series of mentors who saw something special in Sharifa Love–Rutledge helped her stay on the path to being a researcher — and becoming a mentor to others.

Cell biology, microbiology societies present awards
Member News

Cell biology, microbiology societies present awards

September 14, 2020

Honorees include ASBMB members Joann Trejo, James Olzmann, Steven Farber, Sue Wickner and Bernard Moss.

Virtual volunteering in the land of lakes and volcanoes
Outreach

Virtual volunteering in the land of lakes and volcanoes

September 09, 2020

Brandon Roy encourages other scientists to teach students in Nicaragua through the Outreach 360 program